Loading provider…
Loading provider…
Nuclear Medicine Physician in New York, NY
NPI: 1245389956Primary Employer
Trustees of Columbia University in the City of New York
columbiadoctors.org
HQ Phone
Get MD Akiva's Phone Numberphone_androidMobile
Get MD Akiva's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
NC State Medical License
Lehigh Valley Health Network
Internship • Transitional Year
2004 - 2005
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 78306Bone and/or joint imaging, whole body | 35 | 36 |
| 2 | 78226Imaging of liver and bile duct system | 16 | 16 |
| 3 | 78803Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | 16 | 16 |
| 4 | 78598Nuclear medicine study with measurement of blood circulation in the lungs and ventilation | 16 | 16 |
| 5 | 78709Nuclear medicine studies of kidney, blood flow, and function | 11 | 11 |
Pericytes in the Premetastatic Niche
Authors: Ana E. Paiva, Luiza Lousado, Daniel A. P. Guerra, Patrick O. Azevedo, Isadora F. G. Sena, Julia P. Andreotti, Gabryella S P Santos, Ricardo Gonçalves, Akiva Mintz, Alexander Birbrair
Publication Date: 2018-06
Molecular targeting with recombinant cytotoxins of interleukin-13 receptor α2-expressing glioma
Authors: Akiva Mintz, Denise M. Gibo, A. B. Madhankumar, Waldemar Debinski
Publication Date: 2003-08
SP140 inhibits STAT1 signaling, induces IFN-γ in tumor-associated macrophages, and is a predictive biomarker of immunotherapy response.
Authors: Richard Carvajal
Publication Date: 2022-12
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Matching placebo, DRUG: REGN2477
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Sarilumab, DRUG: Tocilizumab, DRUG: Cemiplimab, DRUG: Ubamatamab